Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...
The proposal would affect Medicare plans directly, and CMS is asking for comments on how it might affect employer plans.
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
This cohort study among individuals participating in a weight loss program found that nearly half of those consuming alcohol at baseline decreased their alcohol use after anti-obesity medication ...
Taking anti-obesity drugs has led some U.S. adults to throw away more food than they tossed before starting the medications, ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...
The Biden administration is proposing to cover drugs like Ozempic, which is used to treat heart disease, diabetes and obesity ...
The cost of rolling out such an expansion in coverage would be significant, and a bill authorizing Medicare to cover ...
The Biden-Harris administration wants to expand coverage of anti-obesity medications in the Medicare and Medicaid programs.
Taking anti-obesity drugs has led some U.S. adults to throw away more food than they tossed before starting the medications, a new study has found.